Filter
846
Text search:
assays
Featured
Recommendations
124
New Publications
204
Language
Document type
No document type
448
Guidelines
208
Studies & Reports
92
Manuals
38
Fact sheets
28
Strategic & Response Plan
21
Training Material
5
Situation Updates
3
Resource Platforms
2
Online Courses
1
Countries / Regions
India
47
Western and Central Europe
29
Global
28
Germany
17
Eastern Europe
16
Latin America and the Carribbean
15
Africa
15
South Africa
14
Kenya
13
Russia
12
Uganda
11
Tanzania
11
Sierra Leone
10
Nigeria
10
Brazil
10
East and Southern Africa
10
West and Central Africa
10
Liberia
9
Ukraine
9
Ethiopia
8
Malawi
8
Mozambique
8
Middle East and North Africa
8
Bangladesh
7
Namibia
6
Colombia
6
Nepal
5
Zambia
5
Cambodia
5
Angola
5
USA
4
Syria
4
Argentina
4
Peru
4
South–East Asia Region
4
Venezuela
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
Cameroon
3
Philippines
3
Rwanda
3
Sudan
3
Lesotho
3
Myanmar / Burma
3
Chile
3
Yemen
3
Asia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Ghana
2
Niger
2
Zimbabwe
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Egypt
2
Chad
2
Indonesia
2
Ecuador
2
El Salvador
2
Bolivia
2
Libya
2
Madagascar
2
Eastern Europe and Central Asia
2
Qatar
2
Guinea
1
Guinea-Bissau
1
Morocco
1
Haiti
1
Turkey
1
China
1
Mauritania
1
Benin
1
Dominican Republic
1
Eswatini/ Swaziland
1
Switzerland
1
Cuba
1
Honduras
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
234
Clinical Guidelines
150
Pharmacy & Technologies
48
Public Health
37
Women & Child Health
13
Key Resources
11
Capacity Building
2
Toolboxes
TB
169
COVID-19
122
HIV
108
Rapid Response
56
NTDs
49
Ebola
23
Zika
23
AMR
23
Pharmacy
15
Refugee
14
Polio
10
NCDs
10
Planetary Health
9
Conflict
5
Specific Hazards
5
Mental Health
3
Caregiver
3
Natural Hazards
2
Global Health Education
2
Cholera
1
Health Financing Toolbox
1
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l
...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co
...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e
...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re
...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or
...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The
...
Revised and expanded version of the Guidelines
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm
...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,
...
